- Home
- Publications
- Publication Search
- Publication Details
Title
Gene therapy: a double-edged sword with great powers
Authors
Keywords
-
Journal
MOLECULAR AND CELLULAR BIOCHEMISTRY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-07-21
DOI
10.1007/s11010-020-03834-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CRISPR-engineered T cells in patients with refractory cancer
- (2020) Edward A. Stadtmauer et al. SCIENCE
- Health ministers condemn Novartis lottery for Zolgensma, the world’s most expensive drug
- (2020) Owen Dyer BMJ-British Medical Journal
- Value and affordability of CAR T-cell therapy in the United States
- (2020) Salvatore Fiorenza et al. BONE MARROW TRANSPLANTATION
- Combined Analysis of Clinical Data on HGF Gene Therapy to Treat Critical Limb Ischemia in Japan
- (2020) Ryuichi Morishita et al. CURRENT GENE THERAPY
- Evidence for HIV-1 cure after CCR5Δ32/Δ32 allogeneic haemopoietic stem-cell transplantation 30 months post analytical treatment interruption: a case report
- (2020) Ravindra Kumar Gupta et al. Lancet HIV
- The current state and future directions of RNAi-based therapeutics
- (2019) Ryan L. Setten et al. NATURE REVIEWS DRUG DISCOVERY
- Identification of preexisting adaptive immunity to Cas9 proteins in humans
- (2019) Carsten T. Charlesworth et al. NATURE MEDICINE
- Adopt a moratorium on heritable genome editing
- (2019) Eric S. Lander et al. NATURE
- HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantation
- (2019) Ravindra K. Gupta et al. NATURE
- Luxturna: FDA documents reveal the value of a costly gene therapy
- (2019) Jonathan J. Darrow DRUG DISCOVERY TODAY
- Therapeutic application of the CRISPR system: current issues and new prospects
- (2019) Minyoung Lee et al. HUMAN GENETICS
- The next generation of CRISPR–Cas technologies and applications
- (2019) Adrian Pickar-Oliver et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Onasemnogene Abeparvovec: First Global Approval
- (2019) Sheridan M. Hoy DRUGS
- Volanesorsen: First Global Approval
- (2019) Julia Paik et al. DRUGS
- Principles of and strategies for germline gene therapy
- (2019) Don P. Wolf et al. NATURE MEDICINE
- Gene Therapy
- (2019) Katherine A. High et al. NEW ENGLAND JOURNAL OF MEDICINE
- CRISPR-Edited Stem Cells in a Patient with HIV and Acute Lymphocytic Leukemia
- (2019) Lei Xu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Development and Clinical Translation of Approved Gene Therapy Products for Genetic Disorders
- (2019) Alireza Shahryari et al. Frontiers in Genetics
- Regulators' Advice Can Make a Difference: European Medicines Agency Approval of Zynteglo for Beta Thalassemia
- (2019) Martina Schuessler‐Lenz et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Immunogenicity of Cas9 Protein
- (2019) Aditi Mehta et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- PD-1 disrupted CAR-T cells in the treatment of solid tumors: Promises and challenges
- (2019) Eileen McGowan et al. BIOMEDICINE & PHARMACOTHERAPY
- The approved gene therapy drugs worldwide: from 1998 to 2019
- (2019) Cui-Cui Ma et al. BIOTECHNOLOGY ADVANCES
- Human germline genome editing
- (2019) Rebecca A. Lea et al. NATURE CELL BIOLOGY
- The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs
- (2019) Akin Akinc et al. Nature Nanotechnology
- Oncorine, the World First Oncolytic Virus Medicine and its Update in China
- (2018) Min Liang CURRENT CANCER DRUG TARGETS
- The First Approved Gene Therapy Product for Cancer Ad-p53 (Gendicine): 12 Years in the Clinic
- (2018) Wei-Wei Zhang et al. HUMAN GENE THERAPY
- Gene therapy clinical trials worldwide to 2017: An update
- (2018) Samantha L. Ginn et al. JOURNAL OF GENE MEDICINE
- Repair of double-strand breaks induced by CRISPR–Cas9 leads to large deletions and complex rearrangements
- (2018) Michael Kosicki et al. NATURE BIOTECHNOLOGY
- Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
- (2018) David Adams et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
- (2018) Merrill D. Benson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gene therapy comes of age
- (2018) Cynthia E. Dunbar et al. SCIENCE
- Prevalence of Pre-existing Antibodies to CRISPR-Associated Nuclease Cas9 in the USA Population
- (2018) Vijaya L. Simhadri et al. Molecular Therapy-Methods & Clinical Development
- Inotersen: First Global Approval
- (2018) Susan J. Keam DRUGS
- FDA Approval Summary: Tisagenlecleucel for Treatment of Patients with Relapsed or Refractory B-cell Precursor Acute Lymphoblastic Leukemia
- (2018) Maura C. O’Leary et al. CLINICAL CANCER RESEARCH
- FDA Approval Summary: Axicabtagene Ciloleucel for Relapsed or Refractory Large B-cell Lymphoma
- (2018) Najat Bouchkouj et al. CLINICAL CANCER RESEARCH
- Genetically modified T cells target lymphoma
- (2018) Bianca Nogrady NATURE
- High prevalence of Streptococcus pyogenes Cas9-reactive T cells within the adult human population
- (2018) Dimitrios L. Wagner et al. NATURE MEDICINE
- Benefit-Risk Assessments at the US Food and Drug Administration
- (2017) Robert M. Califf JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- FDA Approval of Tisagenlecleucel
- (2017) Peter B. Bach et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65 -mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial
- (2017) Stephen Russell et al. LANCET
- CRISPR/Cas9-mediated gene editing in human zygotes using Cas9 protein
- (2017) Lichun Tang et al. MOLECULAR GENETICS AND GENOMICS
- Chimeric Antigen Receptors: A Cell and Gene Therapy Perspective
- (2017) Isabelle Rivière et al. MOLECULAR THERAPY
- FDA-Approved Oligonucleotide Therapies in 2017
- (2017) Cy A. Stein et al. MOLECULAR THERAPY
- Therapeutic T cell engineering
- (2017) Michel Sadelain et al. NATURE
- Enhanced proofreading governs CRISPR–Cas9 targeting accuracy
- (2017) Janice S. Chen et al. NATURE
- After Glybera's withdrawal, what's next for gene therapy?
- (2017) Melanie Senior NATURE BIOTECHNOLOGY
- Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy
- (2017) Jerry R. Mendell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Overcoming the Host Immune Response to Adeno-Associated Virus Gene Delivery Vectors: The Race Between Clearance, Tolerance, Neutralization, and Escape
- (2017) Federico Mingozzi et al. Annual Review of Virology
- Gene Therapy for “Bubble Boy” Disease
- (2016) Jonathan Hoggatt CELL
- Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
- (2016) Alexis C. Komor et al. NATURE
- High-fidelity CRISPR–Cas9 nucleases with no detectable genome-wide off-target effects
- (2016) Benjamin P. Kleinstiver et al. NATURE
- A multifunctional AAV–CRISPR–Cas9 and its host response
- (2016) Wei Leong Chew et al. NATURE METHODS
- Defining and improving the genome-wide specificities of CRISPR–Cas9 nucleases
- (2016) Shengdar Q. Tsai et al. NATURE REVIEWS GENETICS
- Eteplirsen therapy for Duchenne muscular dystrophy: skipping to the front of the line
- (2016) James J. Dowling Nature Reviews Neurology
- Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems
- (2016) K. Nishida et al. SCIENCE
- Adenovirus-Mediated Somatic Genome Editing ofPtenby CRISPR/Cas9 in Mouse Liver in Spite of Cas9-Specific Immune Responses
- (2015) Dan Wang et al. HUMAN GENE THERAPY
- Dimeric CRISPR RNA-Guided FokI-dCas9 Nucleases Directed by Truncated gRNAs for Highly Specific Genome Editing
- (2015) Nicolas Wyvekens et al. HUMAN GENE THERAPY
- Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
- (2015) Robert H.I. Andtbacka et al. JOURNAL OF CLINICAL ONCOLOGY
- Gene therapy returns to centre stage
- (2015) Luigi Naldini NATURE
- Therapeutic genome editing: prospects and challenges
- (2015) David Benjamin Turitz Cox et al. NATURE MEDICINE
- Oncolytic viruses: a new class of immunotherapy drugs
- (2015) Howard L. Kaufman et al. NATURE REVIEWS DRUG DISCOVERY
- Rationally engineered Cas9 nucleases with improved specificity
- (2015) I. M. Slaymaker et al. SCIENCE
- CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes
- (2015) Puping Liang et al. Protein & Cell
- First oncolytic virus approved for melanoma immunotherapy
- (2015) Jonathan Pol et al. OncoImmunology
- Promoterless gene targeting without nucleases ameliorates haemophilia B in mice
- (2014) A. Barzel et al. NATURE
- Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo
- (2014) John A Zuris et al. NATURE BIOTECHNOLOGY
- Improving CRISPR-Cas nuclease specificity using truncated guide RNAs
- (2014) Yanfang Fu et al. NATURE BIOTECHNOLOGY
- Fusion of catalytically inactive Cas9 to FokI nuclease improves the specificity of genome modification
- (2014) John P Guilinger et al. NATURE BIOTECHNOLOGY
- Observational study of spinal muscular atrophy type I and implications for clinical trials
- (2014) R. S. Finkel et al. NEUROLOGY
- Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing Specificity
- (2013) F. Ann Ran et al. CELL
- History of gene therapy
- (2013) Thomas Wirth et al. GENE
- Adeno-associated virus (AAV) vectors in gene therapy: immune challenges and strategies to circumvent them
- (2013) Sangeetha Hareendran et al. REVIEWS IN MEDICAL VIROLOGY
- Endgame: Glybera Finally Recommended for Approval as the First Gene Therapy Drug in the European Union
- (2012) Seppo Ylä-Herttuala MOLECULAR THERAPY
- Limb-saving medicines sought to prevent amputations
- (2012) Cassandra Willyard NATURE MEDICINE
- Immune Responses to AAV in Clinical Trials
- (2011) Federico Mingozzi et al. CURRENT GENE THERAPY
- Expression of therapeutic proteins after delivery of chemically modified mRNA in mice
- (2011) Michael S D Kormann et al. NATURE BIOTECHNOLOGY
- Site-specific integration and tailoring of cassette design for sustainable gene transfer
- (2011) Angelo Lombardo et al. NATURE METHODS
- Concise Review: Managing Genotoxicity in the Therapeutic Modification of Stem Cells
- (2011) Christopher Baum et al. STEM CELLS
- Evidence for the cure of HIV infection by CCR5 32/ 32 stem cell transplantation
- (2010) K. Allers et al. BLOOD
- The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy
- (2009) Eugenio Montini et al. JOURNAL OF CLINICAL INVESTIGATION
- The promises and pitfalls of RNA-interference-based therapeutics
- (2009) Daniela Castanotto et al. NATURE
- Long-Term Control of HIV byCCR5Delta32/Delta32 Stem-Cell Transplantation
- (2009) Gero Hütter et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More